225 related articles for article (PubMed ID: 31857679)
21. Immunohistochemical staining patterns of p53 can serve as a surrogate marker for TP53 mutations in ovarian carcinoma: an immunohistochemical and nucleotide sequencing analysis.
Yemelyanova A; Vang R; Kshirsagar M; Lu D; Marks MA; Shih IeM; Kurman RJ
Mod Pathol; 2011 Sep; 24(9):1248-53. PubMed ID: 21552211
[TBL] [Abstract][Full Text] [Related]
22. Molecular Profile of Advanced Thyroid Carcinomas by Next-Generation Sequencing: Characterizing Tumors Beyond Diagnosis for Targeted Therapy.
Chen H; Luthra R; Routbort MJ; Patel KP; Cabanillas ME; Broaddus RR; Williams MD
Mol Cancer Ther; 2018 Jul; 17(7):1575-1584. PubMed ID: 29695638
[TBL] [Abstract][Full Text] [Related]
23. Recurrent chromosomal rearrangements of
Bayard Q; Caruso S; Couchy G; Rebouissou S; Bioulac Sage P; Balabaud C; Paradis V; Sturm N; de Muret A; Guettier C; Bonsang B; Copie C; Letouzé E; Calderaro J; Imbeaud S; Nault JC; Zucman-Rossi J
Gut; 2020 Sep; 69(9):1667-1676. PubMed ID: 31907296
[TBL] [Abstract][Full Text] [Related]
24. High (nuclear) grade adnexal carcinoma with microcystic adnexal carcinoma-like structural features.
Fernández-Figueras MT; Montero MA; Admella J; de la Torre N; Quer A; Ariza A
Am J Dermatopathol; 2006 Aug; 28(4):346-51. PubMed ID: 16871041
[TBL] [Abstract][Full Text] [Related]
25. Cooperation between oncogenic Ras and wild-type p53 stimulates STAT non-cell autonomously to promote tumor radioresistance.
Dong YL; Vadla GP; Lu JJ; Ahmad V; Klein TJ; Liu LF; Glazer PM; Xu T; Chabu CY
Commun Biol; 2021 Mar; 4(1):374. PubMed ID: 33742110
[TBL] [Abstract][Full Text] [Related]
26. Expression of p53 and TP53 mutational analysis in malignant neoplasms arising in preexisting spiradenoma, cylindroma, and spiradenocylindroma, sporadic or associated with Brooke-Spiegler syndrome.
Kazakov DV; Grossmann P; Spagnolo DV; Vanecek T; Vazmitel M; Kacerovska D; Zelger B; Calonje E; Michal M
Am J Dermatopathol; 2010 May; 32(3):215-221. PubMed ID: 20075707
[TBL] [Abstract][Full Text] [Related]
27. Targeting Jak/Stat pathway as a therapeutic strategy against SP/CD44+ tumorigenic cells in Akt/β-catenin-driven hepatocellular carcinoma.
Toh TB; Lim JJ; Hooi L; Rashid MBMA; Chow EK
J Hepatol; 2020 Jan; 72(1):104-118. PubMed ID: 31541681
[TBL] [Abstract][Full Text] [Related]
28. Identification of the JAK-STAT pathway in canine splenic hemangiosarcoma, thyroid carcinoma, mast cell tumor, and anal sac adenocarcinoma.
Cletzer E; Klahn S; Dervisis N; LeRoith T
Vet Immunol Immunopathol; 2020 Feb; 220():109996. PubMed ID: 31958674
[TBL] [Abstract][Full Text] [Related]
29. Rapid Molecular Profiling of Myeloproliferative Neoplasms Using Targeted Exon Resequencing of 86 Genes Involved in JAK-STAT Signaling and Epigenetic Regulation.
Magor GW; Tallack MR; Klose NM; Taylor D; Korbie D; Mollee P; Trau M; Perkins AC
J Mol Diagn; 2016 Sep; 18(5):707-718. PubMed ID: 27449473
[TBL] [Abstract][Full Text] [Related]
30. Epidemiology and Prognosis of Primary Periocular Sweat Gland Carcinomas.
Baker MS; Yin VT; Ivan D; Allen RC; Carter KD; Esmaeli B; Shriver EM
Ophthalmic Plast Reconstr Surg; 2017; 33(2):101-105. PubMed ID: 26974419
[TBL] [Abstract][Full Text] [Related]
31. Distinct Biological Types of Ocular Adnexal Sebaceous Carcinoma: HPV-Driven and Virus-Negative Tumors Arise through Nonoverlapping Molecular-Genetic Alterations.
Tetzlaff MT; Curry JL; Ning J; Sagiv O; Kandl TL; Peng B; Bell D; Routbort M; Hudgens CW; Ivan D; Kim TB; Chen K; Eterovic AK; Shaw K; Prieto VG; Yemelyanova A; Esmaeli B
Clin Cancer Res; 2019 Feb; 25(4):1280-1290. PubMed ID: 30420449
[TBL] [Abstract][Full Text] [Related]
32. Next-generation sequencing analysis suggests varied multistep mutational pathogenesis for endocrine mucin-producing sweat gland carcinoma with comments on INSM1 and MUC2 suggesting a conjunctival origin.
Mathew JG; Bowman AS; Saab J; Busam KJ; Nehal K; Pulitzer M
J Am Acad Dermatol; 2022 May; 86(5):1072-1079. PubMed ID: 33515627
[TBL] [Abstract][Full Text] [Related]
33. The T-cell leukemia-associated ribosomal RPL10 R98S mutation enhances JAK-STAT signaling.
Girardi T; Vereecke S; Sulima SO; Khan Y; Fancello L; Briggs JW; Schwab C; de Beeck JO; Verbeeck J; Royaert J; Geerdens E; Vicente C; Bornschein S; Harrison CJ; Meijerink JP; Cools J; Dinman JD; Kampen KR; De Keersmaecker K
Leukemia; 2018 Mar; 32(3):809-819. PubMed ID: 28744013
[TBL] [Abstract][Full Text] [Related]
34. Merkel cell polyomavirus-negative Merkel cell carcinoma is associated with JAK-STAT and MEK-ERK pathway activation.
Iwasaki T; Hayashi K; Matsushita M; Nonaka D; Kohashi K; Kuwamoto S; Umekita Y; Oda Y
Cancer Sci; 2022 Jan; 113(1):251-260. PubMed ID: 34724284
[TBL] [Abstract][Full Text] [Related]
35. Mixed endometrial carcinomas with a "low-grade serous"-like component: a clinicopathologic, immunohistochemical, and molecular genetic study.
Espinosa I; D'Angelo E; Corominas M; Gonzalez A; Prat J
Hum Pathol; 2018 Jan; 71():65-73. PubMed ID: 29079180
[TBL] [Abstract][Full Text] [Related]
36. Primary cutaneous apocrine carcinoma with RARA::NPEPPS fusion.
Lenskaya V; Yang RK; Cho WC
J Cutan Pathol; 2024 Jun; 51(6):419-423. PubMed ID: 38468567
[TBL] [Abstract][Full Text] [Related]
37. Mining for JAK-STAT mutations in cancer.
Constantinescu SN; Girardot M; Pecquet C
Trends Biochem Sci; 2008 Mar; 33(3):122-31. PubMed ID: 18291658
[TBL] [Abstract][Full Text] [Related]
38. Non-canonical Notch signaling activates IL-6/JAK/STAT signaling in breast tumor cells and is controlled by p53 and IKKα/IKKβ.
Jin S; Mutvei AP; Chivukula IV; Andersson ER; Ramsköld D; Sandberg R; Lee KL; Kronqvist P; Mamaeva V; Ostling P; Mpindi JP; Kallioniemi O; Screpanti I; Poellinger L; Sahlgren C; Lendahl U
Oncogene; 2013 Oct; 32(41):4892-902. PubMed ID: 23178494
[TBL] [Abstract][Full Text] [Related]
39. The JAK/STAT signaling cascade in gastric carcinoma (Review).
Khanna P; Chua PJ; Bay BH; Baeg GH
Int J Oncol; 2015 Nov; 47(5):1617-26. PubMed ID: 26398764
[TBL] [Abstract][Full Text] [Related]
40. JAK/STAT/SOCS-signaling pathway and colon and rectal cancer.
Slattery ML; Lundgreen A; Kadlubar SA; Bondurant KL; Wolff RK
Mol Carcinog; 2013 Feb; 52(2):155-66. PubMed ID: 22121102
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
